Markets
About
Fusion Genomics Corp (FG) is a molecular diagnostic test development company that is introducing diagnostic kits with companion cloud-driven data analysis methodologies that allow hospital and clinical laboratories to leverage Next Generation Sequencing (NGS) technology with minimal effort and expense. FG is the first company in the world to bring a validated NGS diagnostic test complete with highly secure cloud based analytical service for childhood cancers (sarcomas) into the clinic. FG is focused on diagnostic applications where our targeted NGS tests and bioinformatics solutions offer superior clinical information, faster turn-around-times and ease of use for medical professionals. FG is currently developing tests for the absolute diagnosis of pediatric and adult blood cancers: ALL and AML. In addition, FG is now designing tests for the detection of infectious diseases including influenza, hepatitis C, drug resistant tuberculosis and , hemorrhagic fevers which include ebola.